Literature DB >> 23479186

Celastrus orbiculatus Thunb. decreases athero-susceptibility in lipoproteins and the aorta of guinea pigs fed high fat diet.

Ying Zhang1, Yanhong Si, Shutong Yao, Nana Yang, Guohua Song, Hui Sang, Dandan Zu, Xin Xu, Jianhua Wang, Shucun Qin.   

Abstract

Celastrus orbiculatus Thunb. (COT), a traditional Chinese herb, has anti-inflammatory and anti-oxidative properties. In this study, we examined the protective effect of COT on the initiation of atherosclerosis induced by high fat diet and explored the underlying mechanisms. We established guinea pig models of hyperlipidemia and treated them with three dosages of COT or 20 mg/kg/d simvastatin (a positive control drug) for 8 weeks. Plasma lipid analysis indicated that COT decreased total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride (TG), apolipoprotein B100 (apoB100) and apolipoprotein E (apoE) levels and increased high density lipoprotein cholesterol (HDL-C) level. The analysis of the hepatic gene involving cholesterol metabolism by quantitative real-time PCR revealed that COT upregulated the mRNA abundance of LDL receptor (LDL-R), scavenger receptor class B type 1 (SR-B1), cholesterol 7α-hydroxylase A1 (CYP7A1) and the 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR). Oil red O staining showed COT significantly reduced lipid deposition in the arterial wall. Moreover, ELISA assay revealed COT lowered the levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in plasma. Meanwhile, the level of Nitric oxide (NO) in plasma was increased by COT. Immunohistochemistry and Western blot analysis showed the expression of CD68 and active NF-kB p65 proteins in the arterial wall was decreased by COT. The content of Malondialdehyde (MDA) and activity of Superoxide dismutase (SOD) in plasma were determined and the data indicated COT suppressed oxidative stress reaction. These results reveal that administration of COT decreases athero-susceptibility through lowering plasma lipid, attenuating inflammation, and suppressing oxidative stress in guinea pig fed high fat diet.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479186     DOI: 10.1007/s11745-013-3773-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  50 in total

Review 1.  A model of tobacco smoke-induced airflow obstruction in the guinea pig.

Authors:  Joanne L Wright; Andrew Churg
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

Review 2.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells.

Authors:  F Vidal; C Colomé; J Martínez-González; L Badimon
Journal:  Eur J Biochem       Date:  1998-03-15

Review 4.  Animal models for the atherosclerosis research: a review.

Authors:  Li Xiangdong; Liu Yuanwu; Zhang Hua; Ren Liming; Li Qiuyan; Li Ning
Journal:  Protein Cell       Date:  2011-04-06       Impact factor: 14.870

5.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.

Authors:  X C Jiang; C Bruce; J Mar; M Lin; Y Ji; O L Francone; A R Tall
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 6.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

Authors:  Mike Seddon; Yee H Looi; Ajay M Shah
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

7.  Whole body and hepatic cholesterol synthesis rates in the guinea-pig: effect of dietary fat quality.

Authors:  M L Fernandez; N Y Yount; D J McNamara
Journal:  Biochim Biophys Acta       Date:  1990-06-14

8.  Exercise improves plasma lipid profiles and modifies lipoprotein composition in guinea pigs.

Authors:  Wayne Y. Ensign; Donald J. McNamara; Maria Luz Fernandez
Journal:  J Nutr Biochem       Date:  2002-12       Impact factor: 6.048

9.  Hepatic cholesterol metabolism in estrogen-treated men.

Authors:  B Angelin; H Olivecrona; E Reihnér; M Rudling; D Ståhlberg; M Eriksson; S Ewerth; P Henriksson; K Einarsson
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

10.  The effects of jiang-zhi-ning and its main components on cholesterol metabolism.

Authors:  Jianxin Chen; Huihui Zhao; Xueling Ma; Xiao Han; Liangtao Luo; Luya Wang; Jing Han; Bing Liu; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-09       Impact factor: 2.629

View more
  5 in total

1.  Celastrus Orbiculatus Thunb. Reduces Lipid Accumulation by Promoting Reverse Cholesterol Transport in Hyperlipidemic Mice.

Authors:  Ying Zhang; Yanhong Si; Lei Zhai; Shoudong Guo; Jilong Zhao; Hui Sang; Xiaofei Pang; Xue Zhang; Anbin Chen; Shucun Qin
Journal:  Lipids       Date:  2016-03-26       Impact factor: 1.880

2.  Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport in vivo.

Authors:  Yanhong Si; Ying Zhang; Xiaofeng Chen; Lei Zhai; Guanghai Zhou; Ailing Yu; Haijun Cao; Qin Shucun
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-31

Review 3.  Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.

Authors:  Qing Liu; Jianping Li; Adam Hartstone-Rose; Jing Wang; Jiqiang Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

Review 4.  Antioxidants and Atherosclerosis: Mechanistic Aspects.

Authors:  Khojasteh Malekmohammad; Robert D E Sewell; Mahmoud Rafieian-Kopaei
Journal:  Biomolecules       Date:  2019-07-25

5.  Anti-Inflammatory Activity of Diterpenoids from Celastrus orbiculatus in Lipopolysaccharide-Stimulated RAW264.7 Cells.

Authors:  Hyun-Jae Jang; Kang-Hoon Kim; Eun-Jae Park; Jeong A Kang; Bong-Sik Yun; Seung-Jae Lee; Chan Sun Park; Soyoung Lee; Seung Woong Lee; Mun-Chual Rho
Journal:  J Immunol Res       Date:  2020-07-30       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.